State Street Corporation 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-18 08:38 am Sale | 2024-09-30 | 13G | Iovance Biotherapeutics, Inc. IOVA | STATE STREET CORP STT | 13,201,978 4.400% | -3,222,410 (-19.62%) | Filing |
| 2024-01-25 10:49 am Purchase | 2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | STATE STREET CORP STT | 16,424,388 6.420% | 1,708,913 (+11.61%) | Filing |
| 2023-02-02 12:29 pm Purchase | 2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | STATE STREET CORP STT | 14,715,475 9.320% | 14,715,475 (New Position) | Filing |